{
    "code": 0,
    "data": [
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended On December 31 2025",
            "news_body": "The Board of Directors of the Company in their Meeting held on February 11 2026 has inter-alia considered and approved the Un-Audited Financial Results of the Company along with the Limited Review Report for the Quarter and Nine Months ended on December 31 2025.",
            "news_id": "5b0a9fef-94b3-40cf-b93e-bafadb8ce985",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df9e3cc9-3a03-4f4a-85c0-06eb4c1250b3.pdf",
            "news_date": "2026-02-11 17:44:31",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025",
            "news_body": "The Board of Directors of the Company in the Meeting held on November 11 2025 has inter-alia considered and approved the Unaudited Financial Results of the Company along with the Limited Review Report issued by the Statutory Auditors for the Quarter and Half Year ended September 30 2025.",
            "news_id": "72715064-0568-4194-9b1e-35ca75b4ecd7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6eac122d-dc0b-4cfd-b2e8-18656852940b.pdf",
            "news_date": "2025-11-11 17:32:47",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30 2025",
            "news_body": "Unaudited Financial Results for the Quarter Ended June 30 2025.",
            "news_id": "bad5ebbc-863d-4711-be0a-3c2eae2c5ea5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94ab99b2-5474-4253-9183-8e8712089137.pdf",
            "news_date": "2025-08-12 16:52:57",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter & Year Ended March 31 2025",
            "news_body": "Audited Financial Results of the Company for the Quarter & Year ended March 31 2025.",
            "news_id": "21904763-5fa3-4635-86cb-c3779eeff876",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c83770de-43dd-45d0-8284-76f7a45e2481.pdf",
            "news_date": "2025-05-26 17:39:23",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended 31/12/2024",
            "news_body": "Unaudited Financial Results for the Quarter and Nine Months ended 31/12/2024",
            "news_id": "2145c147-0e2d-4ddd-bb5a-a61f4bb91d2f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9a908db-934c-4781-9fc3-db76362112d9.pdf",
            "news_date": "2025-02-06 17:02:08",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30.09.2024",
            "news_body": "Unaudited Financial Results for the Quarter ended 30.09.2024",
            "news_id": "3f53c6af-4d9f-498f-9112-78de1db298ae",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fc8c8c54-7062-45a3-a7de-09516e8012d1.pdf",
            "news_date": "2024-11-11 17:07:50",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 11/11/2024",
            "news_body": "The Board of Directors in the meeting held on 11/11/2024 has inter-alia approved Unaudited Financial Results of the Company for the Quarter and Half Year ended September 30,2024 along with the Limited Review Report",
            "news_id": "69db40c5-e018-4a5c-9884-6774c5050655",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb15c923-90fa-49eb-a515-bb695b49351b.pdf",
            "news_date": "2024-11-11 17:02:24",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended 30.06.2024",
            "news_body": "Unaudited Financial Results for the Quarter ended 30.06.2024",
            "news_id": "87a3b7c6-e1f8-4817-ba5b-ecb3e4e01933",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26c45804-7d01-4e2d-9909-a2593c7c9f73.pdf",
            "news_date": "2024-08-13 15:58:43",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results Of The Company For The Quarter & Year Ended 31/03/2024",
            "news_body": "We are herewith submitting the Audited Financial Results for the Quarter & Year ended 31/03/2024",
            "news_id": "df070be2-14d5-4f59-9901-8bd2bb42d937",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=033fb19e-35d8-4008-bec4-9fb14906be2e.pdf",
            "news_date": "2024-05-29 19:05:31",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Standalone Financial Results For The Quarter Ended December 31, 2023.",
            "news_body": "we wish to inform that at the meeting of the Board of Directors of the Company held today i.e., February 12, 2024, Monday, the results of the quarter ended on December 31, 2023, duly reviewed by Audit Committee, inter-alia has been considered and approved by the Board of Directors of the Company.",
            "news_id": "11534dc6-b18c-4eea-ae6e-4697561d16ba",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fac9078e-2a9e-49de-b806-a7f5e13340eb.pdf",
            "news_date": "2024-02-12 17:08:43",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended September 2023.",
            "news_body": "we wish to inform that at the meeting of the Board of Directors of the Company held on November 09, 2023, the results for the quarter ended September 30, 2023, duly reviewed and recommended by the Audit Committee, inter-alia, has been considered and approved by the Board of Directors of the Company.",
            "news_id": "59524501-e8f1-44a9-8d94-28de4219d024",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=231b0c5b-0a73-414b-b100-8b595c2982ca.pdf",
            "news_date": "2023-11-10 15:26:24",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Approval Of Un-Audited Financial Results Of The Company For The II Quarter And Half Year Ended September 30, 2023, For The FY 2023-24.",
            "news_body": "We wish to inform that at the meeting of the Board of Directors of the Company held today i.e., November 09, 2023, Thursday, the results for the quarter and half-year ended on September 30, 2023, duly reviewed and recommended by the Audit Committee, inter-alia, has been considered and approved by the Board of Directors of the Company.<BR> In this regard, we enclose the following:<BR>   <BR>",
            "news_id": "5478bd7b-d14d-4cdc-9575-d19b5a8c7335",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d8543ab-a641-49f2-9e18-71ef2b1c6ec3.pdf",
            "news_date": "2023-11-09 16:56:46",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended June 30, 2023.",
            "news_body": "the Board of Director of Bafna Pharmaceuticals Limited approved the Financial results for the quarter ended June 30, 2023.",
            "news_id": "2ceb2c04-f952-4409-9655-b238f4cdc87f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b6d9276-ea16-4256-8c2e-74d2ec87db7e.pdf",
            "news_date": "2023-08-12 12:09:57",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Year Ended March, 31 2023.",
            "news_body": "We herewith submit the Audited Financial results (standalone) for the quarter and year ended March 31, 2023, which was approved by the Board Of Directors in the Meeting held on 27.05.2023",
            "news_id": "48667ea2-b42c-4e96-bb74-0a9a25b6ed3f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf011be9-abaa-40bb-bea6-c382f44236ec.pdf",
            "news_date": "2023-05-27 16:01:54",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended 31.12.2022",
            "news_body": "Unaudited financial results for the quarter and nine months ended 31.12.2022 along with limited review report",
            "news_id": "209bc13d-61fb-412e-8e31-709c4b0c4f82",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1fc6f6f7-facc-4d9c-9bfd-3b2ee32505a3.pdf",
            "news_date": "2023-02-08 14:11:15",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On 11.11.2022",
            "news_body": "Outcome of the Meeting of Board of Directors held on 11.11.2022",
            "news_id": "21d328ac-e44d-4a47-a254-9f8a8d3623c7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33d80466-a52b-4f3c-a882-fc364889a23e.pdf",
            "news_date": "2022-11-11 13:44:01",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for .:- Regulation 30 Read With Reg. 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015                                         <BR> <BR>",
            "news_body": "We would like to inform you that the Board at its meeting held today approved the unaudited financial results for the quarter ended 30th June 2022. <BR> <BR> Please find attached the unaudited financial results for the quarter ended 30th June 2022 along with the limited review report obtained from the statutory auditor of the Company.<BR> <BR> The Audit Committee of the Company has been reconstituted to include Ms. Chitra Ravichandran, Independent Director as member of the Committee.   <BR> <BR>",
            "news_id": "8e0b226f-2915-4a80-a40e-7235c6833cfe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=95cdb490-1be7-4110-bc43-5a66945830b6.pdf",
            "news_date": "2022-08-11 13:36:11",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On 26Th May 2022",
            "news_body": "1. AUDITED FINANCIAL RESULTS<BR> <BR> Approval of audited financial results of the Company for the quarter and year ended 31st March 2022. <BR> <BR> Please find enclosed the following:<BR> <BR> 1.  Audited financial statements (standalone) for the quarter and year ended 31st March 2022 along with Auditor's report for the said period<BR> <BR> 2. Declaration on Unmodified Opinion in the Auditors' Report for Financial Year ended March 31, 2022<BR> <BR> <BR> 2. ANNUAL GENERAL MEETING<BR> <BR> The 27th Annual General Meeting of the members of the Company is scheduled to be held on Thursday, 28th July 2022 at 12:00 Noon through video conferencing and other audio visual means. <BR> <BR>  <BR> <BR> <BR> <BR> <BR> <BR> <BR> <BR> 3. To open wholly owned subsidiary of Bafna Pharmaceuticals Limited in Australia.<BR>",
            "news_id": "a3a464cc-5e44-4228-be8e-31444c12d649",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46ae147a-22b7-443b-9a38-9aaf8addc519.pdf",
            "news_date": "2022-05-26 14:55:10",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Result",
            "news_body": "We would like to inform you that the Board at its meeting held on today approved:<BR> <BR> 1. The un-audited financial results for the Third Quarter ending 31st December 2021. Please find attached the un-audited financial results for Third Quarter ending 31st December 2021 along with the Limited Review Report obtained from the statutory auditor of the Company",
            "news_id": "11961fa2-8a54-4a5c-8b13-f8e80bca5e5c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=caed8097-258e-4824-8233-612584a25241.pdf",
            "news_date": "2022-02-10 16:26:29",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Result For The Half Year Ending 30Th Sep 2021",
            "news_body": "1. Approved the un - audited financial results of the Company for the quarter /half year ended September 30, 2021. Please find attached Limited Review Report from the Statutory Auditor.<BR> 2. Statutory Auditors comments along with Management's Reply:<BR>",
            "news_id": "6f11079d-a891-4382-a360-503cb9e9ef2b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=228412b2-6d4a-44a8-bb08-bc5a2b939e35.pdf",
            "news_date": "2021-11-12 14:28:06",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, ('Listing Regulations') as amended, this is to inform you that the Board of Directors ('Board') of the Company, had at its meeting held today i.e. Friday, November 12, 2021, the Board has decided the following matters:<BR> 1. Approved the un - audited financial results of the Company for the quarter /half year ended September 30, 2021. Please find attached Limited Review Report from the Statutory Auditor.<BR> 2. Statutory Auditors comments along with Management's Reply:<BR> 3. Raising of funds by way of offer and issue of equity shares to the existing shareholders of the Company on a rights basis (Rights Issue) for an aggregate amount upto INR 50 Crore.    <BR>",
            "news_id": "aa614d05-554a-411a-b2c6-d32e913f2dd1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f639df1-538d-4db5-a820-17e97225b043.pdf",
            "news_date": "2021-11-12 14:20:57",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Q1 2021-22 Results",
            "news_body": "The Board of Directors of the Company at their meeting held on today inter-alia transacted the following business.:-<BR> <BR> 1. UN-AUDITED FINANCIAL RESULT<BR> <BR> Approval of un-audited financial results of the Company for the quarter ending 30th June 2021. Please find attached  Limited Review Report from the statutory auditor of the Company M/s. R. Sathyanarayanan & Co.<BR> <BR>",
            "news_id": "02a14d57-5c30-4fb7-a9af-9db88d39b91e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7fdc016e-3355-45bb-90e6-de1e4e06447d.pdf",
            "news_date": "2021-08-05 17:00:11",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On 05Th August 2021",
            "news_body": "The Board of Directors of the Company at their meeting held on today inter-alia transacted the following business.:-<BR> <BR> 1. UN-AUDITED FINANCIAL RESULT   <BR> <BR> Approval of un-audited financial results of the Company for the quarter ending 30th June 2021. Please find attached  Limited Review Report from the statutory auditor of the Company M/s. R. Sathyanarayanan & Co.<BR>",
            "news_id": "a49e692b-d213-4195-926b-4b1e23d73bfe",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=423c847c-9495-4ebb-980b-2bf7c49fa447.pdf",
            "news_date": "2021-08-05 14:03:53",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Discrepancies In Standalone Financial Results",
            "news_body": "We acknowledge the receipt of your email dated 17th July 2021 and our reply is as follow:<BR> <BR> Discrepancy: In PDF of Cash Flow Statement - Closing Balance of Cash & Cash Equivalent Not Tallying.(Confirm Net Increase/ [Decrease] In Cash or cash Equivalents Figure is Positive & Negative).Kindly File Rectified Figures of Cash Flow Statement.<BR> <BR> Company's Reply<BR> <BR> Revised Cash Flow Statement is attached herewith.<BR>",
            "news_id": "3011a27f-ef10-4542-a272-8e294825f2bc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a131913b-36cc-409c-86e7-873ec7a47558.pdf",
            "news_date": "2021-07-26 16:52:13",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Sub.:- Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Details Of Related Party Transactions<BR> <BR>",
            "news_body": "Pursuant to Regulation 23(9) of the Listing Regulations, please find enclosed herewith the disclosure of related party transactions for the half-year ended March 31, 2021.<BR> <BR> This is for your information and record.<BR>",
            "news_id": "97bb156a-4839-4197-b8d2-6d9039b655d5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aaf5137d-f3f2-43e6-aab6-0f03af797cb9.pdf",
            "news_date": "2021-07-09 15:38:54",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Result For The Year Ending 31.03.2021",
            "news_body": "1. AUDITED FINANCIAL RESULT<BR> <BR> Approval of audited financial results of the Company for the quarter and year ending 31st March 2021.  M/s. R. Sathyanarayanan & Co, Chartered Accountant, the Statutory Auditors of the Company have issued Audit Report with modified opinion along with Statement on impact of Modified opinion thereon.<BR> <BR> Please find enclosed 'Audited Financial Results, Audit Report, 'Statement of Assets & Liabilities' and Statement on Impact of Modified Opinion thereon for the year ended on March 31, 2021.<BR> <BR> 2. ANNUAL GENERAL MEETING<BR> <BR> The 26th Annual General Meeting of the members  of the Company  is scheduled  to be held on Saturday the 14th August 2021.<BR> <BR>",
            "news_id": "ad4d5a22-66e6-4d38-ab79-3fb5c23da717",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d639a7a-78a8-4f0b-a9a2-621ccdf74259.pdf",
            "news_date": "2021-06-25 15:35:48",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "1. AUDITED FINANCIAL RESULT<BR> <BR> Approval of audited financial results of the Company for the quarter and year ending 31st March 2021.  M/s. R. Sathyanarayanan & Co, Chartered Accountant, the Statutory Auditors of the Company have issued Audit Report with modified opinion along with Statement on impact of Modified opinion thereon.<BR> <BR> Please find enclosed 'Audited Financial Results, Audit Report, 'Statement of Assets & Liabilities' and Statement on Impact of Modified Opinion thereon for the year ended on March 31, 2021.<BR> <BR> 2. ANNUAL GENERAL MEETING<BR> <BR> The 26th Annual General Meeting of the members  of the Company  is scheduled  to be held on Saturday the 14th August 2021.<BR> <BR>",
            "news_id": "acbb9d6f-177a-4b5f-83d2-4f29fd692cf9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99705397-2625-41ff-b2ee-8cc2412443f7.pdf",
            "news_date": "2021-06-25 15:24:18",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held On 12Th February 2021",
            "news_body": "We would like to inform you that the Board at its meeting held on today approved:<BR> <BR> 1. The un-audited financial results for the Third Quarter ending 31st December 2020. Please find attached the un-audited financial results for Third Quarter ending 31st December 2020 along with the Limited Review Report obtained from the statutory auditor of the Company<BR>",
            "news_id": "fe189fdb-4500-4e80-a7c5-b980cdbb432e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1d4d698-35f5-4dab-ac24-179a8d7e80e0.pdf",
            "news_date": "2021-02-12 14:45:41",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BAFNAPH",
            "disp": "Bafna Pharmaceuticals",
            "bse_code": 532989,
            "isin": "INE878I01022",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "We would like to inform you that the Board at its meeting held on today approved:<BR> <BR> 1. The un-audited financial results for the Third Quarter ending 31st December 2020. Please find attached the un-audited financial results for Third Quarter ending 31st December 2020 along with the Limited Review Report obtained from the statutory auditor of the Company.<BR> <BR>",
            "news_id": "f7c2c668-c27b-438a-9b8d-591986de21e5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee743fdc-71e7-46df-bf47-7959c9a73860.pdf",
            "news_date": "2021-02-12 14:38:06",
            "seo": "bafna-pharmaceuticals-ltd",
            "ltp": 128.26,
            "ch": 0.36999999999999034,
            "pch": 0.28931112674954285,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 17735,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}